UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Improving study conduct and data quality in clinical trials of chronic pain treatments: IMMPACT recommendations

Gewandter, JS; Dworkin, RH; Turk, DC; Devine, EG; Hewitt, D; Jensen, MP; Katz, NP; ... Witter, J; + view all (2019) Improving study conduct and data quality in clinical trials of chronic pain treatments: IMMPACT recommendations. The Journal of Pain 10.1016/j.jpain.2019.12.003. (In press).

[img] Text
Kirkwood_Gewandter_IMMPACT -data quality_in press.pdf - Accepted version
Access restricted to UCL open access staff until 14 December 2020.

Download (709kB)

Abstract

The estimated probability of progressing from phase 3 analgesic clinical trials to regulatory approval is approximately 57%, suggesting that a considerable number of treatments with phase 2 trial results deemed sufficiently successful to progress to phase 3 do not yield positive phase 3 results. Deficiencies in the quality of clinical trial conduct could account for some of this failure. An Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) meeting was convened to identify potential areas for improvement in trial conduct in order to improve assay sensitivity (i.e., ability of trials to detect a true treatment effect). We present recommendations based on presentations and discussions at the meeting, literature reviews, and iterative revisions of this article. The recommendations relate to the following areas: (1) study design (i.e., to promote feasibility), (2) site selection and staff training, (3) participant selection and training, (4) treatment adherence, (5) data collection, and (8) data and study monitoring. Implementation of these recommendations may improve the quality of clinical trial data and thus the validity and assay sensitivity of clinical trials. Future research regarding the effects of these strategies will help identify the most efficient use of resources for conducting high quality clinical trials. / Perspective: Every effort should be made to optimize the quality of clinical trial data. This manuscript discusses considerations to improve conduct of pain clinical trials based on research in multiple medical fields and the expert consensus of pain researchers and stakeholders from academia, regulatory agencies, and industry.

Type: Article
Title: Improving study conduct and data quality in clinical trials of chronic pain treatments: IMMPACT recommendations
Location: United States
DOI: 10.1016/j.jpain.2019.12.003
Publisher version: https://doi.org/10.1016/j.jpain.2019.12.003
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification: UCL
UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > CRUK Cancer Trials Centre
URI: https://discovery.ucl.ac.uk/id/eprint/10089383
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item